热门资讯> 正文
森科拉因沃尔格林部分业务的损失而下跌
2026-08-13 01:20
- Cencora (COR) shares fell in afternoon trading on Wednesday after the medical distributor disclosed that some of its business operations that previously served the pharmacy chain Walgreens are moving outside.
- The company formerly known as AmerisourceBergen said that certain business operations that previously served Walgreens, outside a prime vendor agreement between the two firms, moved to external parties, effective July 1, 2026.
- However, the prime vendor agreement remains intact and represents a significant majority of the business it does with Walgreens, Cencora (COR) added in a regulatory filing.
- The company reaffirmed its FY26 outlook for adjusted diluted earnings per share at $17.75 - $17.95, in line with $17.86 in the consensus. The situation was disclosed alongside its Q4 outlook for its U.S. Healthcare Solutions segment issued earlier this month, Cencora (COR) said.
More on Cencora
- Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript
- Cencora, Inc. 2026 Q3 - Results - Earnings Call Presentation
- Cencora: Specialty Infrastructure Is Rewriting The Distributor Model
- Cencora outlines fiscal 2026 EPS of $17.75-$17.95 while maintaining ~$3B free cash flow target
- Cencora beats top-line and bottom-line estimates; updates FY26 outlook
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。